Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
MNCs Need Perseverance as China Ratchets Up Cost Containment amid Economic Woes
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on strategic thinking and vision on the Chinese pharmaceutic... (4/1/2019)
   
Rare Diseases in China, Their High Treatment Costs, and the People Publicizing Patients' Plight (4/18/2019)
Pharmaceutical Antitrust in China (4/17/2019)
Bayer Pharma Hit with China-attributed Malware (4/16/2019)
'Reverse Patent Trolls' Plague Big Pharma in China (4/16/2019)
FDA'S Pazdur Encourages Chinese Companies To Bring Low-Cost PD-1 Drugs To U.S. Market (4/3/2019)
PharmExec: Use of External Innovation in China (4/3/2019)
MNCs Need Perseverance as China Ratchets Up Cost Containment amid Economic Woes (4/1/2019)
3 Key Takeaways From BeiGene's CEO (3/26/2019)
Why China's New Legal Framework Will Be A Magnet for Global Pharmaceuticals (3/21/2019)
MAH Program A Shot in the Arm for Chinese Pharmaceutical Industry (3/19/2019)
5 Key Elements of Chinese Biopharma's "Cambrian Explosion" (3/17/2019)
A Merck Cancer Treatment Has a Big Opportunity in China, Analyst Says (3/13/2019)
China Sends Mixed Signals for Healthcare as Outlook Shift from Cautious Optimism to Cautious Pessimism for Many (3/1/2019)
New IFPMA Code of Practice Tightens Restrictions on Gifts (with Case on RDPAC Code Changes) (2/27/2019)
Chinese Biotech Feels Chill in Harsh Winter for Venture Capital (2/26/2019)
Amendment of Drug Administration Law and...  (4/22/2019)
China to Amend Healthcare Laws Relating ...  (4/22/2019)
NMPA Solicits Comments on Draft Announce...  (4/19/2019)
Recent Executive Moves  (4/19/2019)
I-Mab Signs Agreement with Roche for Cli...  (4/18/2019)
HitGen Achieves Milestone from DEL Disco...  (4/18/2019)
U.S. Senators Propose Bill to Sanction C...  (4/18/2019)
Lonza's Specialty API Business Disrupted...  (4/18/2019)
Rexahn Pharma, BioSense Global Announce ...  (4/17/2019)
CASI In-Licenses Exclusive Worldwide Rig...  (4/17/2019)
GSK CEO Pledges to Learn from Mistakes i...  (4/17/2019)
NMPA Issues the Chinese Edition of ICH G...  (4/17/2019)
NHSA Issues the Action Plan for 2019 Nat...  (4/17/2019)
NHC Pledges More Efforts to Address Medi...  (4/17/2019)
I-Mab Bio and WuXi Bio Announce Long-ter...  (4/16/2019)
IQVIA: Global Pharma to Grow Slower in the Next Five Yea...
Pfizer and GSK Announce JV to Create a Global Consumer H...
Top 25 Global Pharmaceutical Companies by Market Cap 201...
CANbridge Receives IND Approval to Commence CAN008 Phase...
Global Contract Pharmaceutical Manufacturing Market to R...
Chinese Import of Medicine and Health Products Down in 2018 Due...
Nicholas Hall Reports 8% Growth of OTC Gastrointestinal Market ...
Nicholas Hall's Review of China's OTC Drug Market Performance 2...
Review and Outlook of China's Foreign Trade of Medicines and He...
Chinese Diabetes Drug Market Continues to be Dominated by MNCs ...
China to Amend Healthcare Laws Relating to Physicians
HitGen Achieves Milestone from DEL Discovery Alliance with M...
Rexahn Pharma, BioSense Global Announce License Agreement fo...
CASI In-Licenses Exclusive Worldwide Rights to Novel Anti-CD...
GSK CEO Pledges to Learn from Mistakes in the Booming Chines...
NMPA Solicits Comments on Draft Announcement for Nature ...
NMPA Issues the Chinese Edition of ICH Guideline M4 Docu...
CDE Seeks Comments on Draft ICH Guideline M10
CDE Publicizes Six More Drug Applications To Be Granted ...
China Plans to Issue A New Set of Standards for Stem Cel...
Amendment of Drug Administration Law and Draft Vaccine Manag...
China Said to be Back-paddling on Pharma IP Stances as High-...
USTR's 2018 Report for China's WTO Compliance Highlight IP I...
Report: China Tightens IP Protection and Expands Patent Refo...
China Claims Steady Progress in Key Indicators of IP in 2018...
U.S. Senators Propose Bill to Sanction Chinese Pharmchem...
Lonza's Specialty API Business Disrupted by Chinese Plan...
Huahai Pharma Involved In Another Blood Pressure Drug Re...
Novo Nordisk Pharmatech A/S signs Asia Pacific distribut...
Trade Bodies Warns API Supply Chain Disruptions from Chi...
I-Mab Signs Agreement with Roche for Clinical Research o...
MSK-CTONG Collaboration Will Accelerate US-China Clinica...
CStone Gains Chinese IND Approval for Avapritinib Phase ...
LSK BioPharma and Hengrui Medicine Announce FDA Clearanc...
Novartis Submits New Drug Application for Gilenya (Fingo...
NHSA Issues the Action Plan for 2019 National Reimbursem...
NHC Pledges More Efforts to Address Medicine Shortage
NHC Publishes Report on Status Quo of Chinese Antibiotic...
Ant Financial Aims to Disrupt China’s Health Insurance ...
NHSA Solicits Comments on Draft Rules for Use of Basic M...
Recent Executive Moves
Chairman of Sunflower Pharma Arrested for Murder
Recent Executive Moves
Recent Executive Moves
Recent Executive Movements
Upcoming Event: Pharma China Annual Forum 2019 (April 9,...
Pharma China Annual Forum 2019 (April 9, Shanghai)
Upcoming: Auction - Pharma Site Closure in XiAn, China (...
Pharma China Annual Forum 2019 (April 9, Shanghai)
Upcoming Event: 4th Asean Pharma Packaging Conference
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON to Hold Pharma China Ann...
  WiCON Publishes the China Phar...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links